Evolution of hepatic fibrosis and steatosis during long-term use of metformin in patients with type 2 diabetes

被引：0

作者：

Lee, Hye Won ^{[1
]}

Kim, Seung Up ^{[1
]}

Lee, Jae Seung ^{[1
]}

Kim, Beom Kyung ^{[1
]}

Park, Jun Yong ^{[1
]}

Kim, Do Young ^{[1
]}

Ahn, Sang Hoon ^{[1
]}

Han, Kwang-Hyub ^{[1
]}

机构：

[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU032

引用

页码：S156 / S157

页数：2

共 50 条

[1] Hepatic steatosis predicts fibrosis in long-term methotrexate use [J].

Tomaszewski, Marcel ;

Dahiya, Monica ;

Mohajerani, Amir ;

Ko, Hin Hin ;

Punja, Hanaa ;

Ramji, Alnoor .

JOURNAL OF HEPATOLOGY, 2020, 73 :S232-S232

[2] Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years [J].

Lee, Hye Won ;

Lee, Jae Seung ;

Kim, Beom Kyung ;

Park, Jun Yong ;

Kim, Do Young ;

Ahn, Sang Hoon ;

Kim, Seung Up .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (01)

[3] Triple therapy with pioglitazone/exenatide/metformin prevents hepatic fibrosis and steatosis in type 2 diabetes [J].

Lavrynenko, O. ;

Abdul-Ghani, M. ;

Alatrach, M. ;

Puckett, C. ;

Adams, J. ;

Cersosimo, E. ;

Alkhouri, N. ;

DeFronzo, R. A. .

DIABETOLOGIA, 2020, 63 (SUPPL 1) :S66-S67

[4] High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus [J].

Gupta, Aanchal ;

Anoop, Shajith ;

Ansari, Irshad Ahmad ;

Prakash, Satya ;

Misra, Anoop .

CLINICAL NUTRITION ESPEN, 2021, 46 :519-526

[5] Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes [J].

Lingvay, Ildiko ;

Raskin, Philip ;

Szczepaniak, Lidia S. .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) :137-142

[6] The Long-Term Cardiovascular Effects of Metformin on Patients with Newly Diagnosed Type 2 Diabetes [J].

Yue, Tong ;

Wang, Xulin ;

Zhao, Minzhe ;

Weng, Jianping ;

Luo, Sihui ;

Zheng, Xueying .

DIABETES, 2023, 72

[7] LONG-TERM EVOLUTION LIVER TUMORIGENESIS, STEATOSIS AND FIBROSIS SCORES AFTER INTRAPORTAL ISLET TRANSPLANTATION IN TYPE 1 DIABETES [J].

Benomar, K. ;

Pigny, P. ;

Mathurin, P. ;

Boury, S. ;

Caiazzo, R. ;

Pattou, F. ;

Kerr-Conte, J. ;

Vantyghem, M. C. .

TRANSPLANT INTERNATIONAL, 2016, 29 :6-6

[8] Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use [J].

Tomaszewski, Marcel ;

Dahiya, Monica ;

Mohajerani, Seyed Amir ;

Punja, Hanaa ;

Ko, Hin Hin ;

Sun, Muxin ;

Ramji, Alnoor .

CANADIAN LIVER JOURNAL, 2021, 4 (04) :370-380

[9] Diabetes: Long-term metformin exposure linked with peripheral neuropathy in patients with type 2 diabetes mellitus [J].

Osório J. .

Nature Reviews Endocrinology, 2010, 6 (3) :121-121

[10] Effect of Canagliflozin on Markers of Hepatic Steatosis and Fibrosis in Patients With Type 2 Diabetes and CKD [J].

Koshino, Akihiko ;

Oshima, Megumi ;

Arnott, Clare G. ;

Fletcher, Robert A. ;

Perkovic, Vlado ;

Heerspink, Hiddo J. L. ;

Neuen, Brendon L. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11) :673-674

← 1 2 3 4 5 →